- Home
- ZNB vs KYNB Comparison
ZNB vs KYNB Comparison
Compare ZNB & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNB | KYNB |
|---|---|---|
| Founded | N/A | 1993 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 31.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNB | KYNB |
|---|---|---|
| Price | $0.20 | $7.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 37.0K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $6.67 |
| 52 Week High | $5.22 | $9.58 |
Technical Indicators
Market Signals| Indicator | ZNB | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 32.73 | 46.67 |
| Support Level | $0.19 | $7.37 |
| Resistance Level | $0.30 | $8.89 |
| Average True Range (ATR) | 0.03 | 0.49 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 8.79 | 30.60 |
Price Performance
Historical ComparisonAbout ZNB Zeta Network Group Class A Ordinary Shares
Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.